NLRP3 and colitis: A dual-acting synthetic molecule and inhibitor termed 10 v has recently been suggested to attenuate in vivo induced-colitis by disrupting ASC interaction for proper NLRP3 and AIM-2 function as well as signal transducers and activators of transcription (STAT) signaling pathways [162].